Journal of the American Academy of Dermatology
Volume 61, Issue 2 , Pages e5-e8, August 2009

Pregnancy outcomes in psoriasis: Why do we know so little?

  • Elizabeth J. Horn, PhD, MBI

      Affiliations

    • International Psoriasis Council, Dallas, Texas
    • ,
  • Christina D. Chambers, PhD, MPH

      Affiliations

    • Department of Pediatrics, University of California San Diego and Rady Children's Hospital, San Diego, California
    • ,
  • Alan Menter, MD

      Affiliations

    • Department of Dermatology, Baylor University Medical Center, Dallas, Texas
    • ,
  • Alexa B. Kimball, MD, MPH

      Affiliations

    • Departments of Dermatology at Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence to: Alexa B. Kimball, MD, MPH, Massachusetts General Hospital, 50 Staniford St, #246, Boston, MA 02114.
    • ,
  • International Psoriasis Council

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding for this work was provided by Astellas Pharma, which had no influence on the content or construction of this paper.

 Disclosure: Dr Horn consults with the International Psoriasis Council. Dr Chambers receives grant funding from Amgen, Abbott, Apotex, Bristol-Myers Squibb, Barr Laboratories, Sanofi-Pasteur, Sanofi-Aventis, Sandoz, Kali Laboratories, and TEVA Pharmaceuticals. Dr Menter has served as a consultant, investigator, speaker, or advisory board member for Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Warner Chilcott, and Wyeth. Dr Kimball has served as a consultant and investigator for Amgen, Centocor, Abbott Laboratories, Neostrata, and Galderma. She is an investigator for Stiefel. She has a fellowship program funded by Centocor.

 Reprint requests should be directed to harvardskinstudies@partners.org.

PII: S0190-9622(09)00554-4

doi:10.1016/j.jaad.2009.05.004

Journal of the American Academy of Dermatology
Volume 61, Issue 2 , Pages e5-e8, August 2009

Article Tools